NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

CUSIP: 641288105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
33,235,472
Total 13F shares
20,868,828
Share change
+794,251
Total reported value
$233,522,000
Put/Call ratio
3.4%
Price per share
$11.19
Number of holders
61
Value change
+$8,990,314
Number of buys
33
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 641288105?
CUSIP 641288105 identifies NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q4 2024

As of 31 Dec 2024, NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,868,828 shares. The largest 10 holders included KCK LTD., ORBIMED ADVISORS LLC, MORGAN STANLEY, Soleus Capital Management, L.P., Kent Lake PR LLC, VANGUARD GROUP INC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, and Nantahala Capital Management, LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.